Medication info

Mgnesium 10% Injection (Magnesium Sulfate Hydrate)

Prescription medicationInjectionsIntramuscular injection · Intravenous injection
Ingredient · strength
Magnesium Sulfate Hydrate›0.1g / 1mL
Manufacturer / importer
Green Cross Wellbeing Co., Ltd.
Appearance
Brown ampoule containing a colorless and transparent liquid or injection in a colorless and transparent plastic container
Packaging
5 mL (ampoule) × 50 ampoules 20 mL (plastic ampoule) × 50 ampoules
Approval status
Active

MFDS item code 201310661 · Notified 2013.12.12

Summary

Main use
Electrolyte supplementation; suppression of convulsions and seizures (hypomagnesemia, eclampsia); prevention of uterine rigidity
Who receives it
Adults · Children
Adult administration
○ Convulsions due to hypomagnesemia: Inject 1 ∼ 2 g of magnesium sulfate intravenously (4.05 ∼ 8.1 mmol). ○ Eclamptic seizures: Inject 4 ∼ 5 g of this drug intravenously over 10 minutes (16.2 ∼ 20.25 mmol). ○ Prevention of uterine rigidity: Initially inject 4 g of this drug intravenously (16.2 mmol). A further 1 g may be administered. ○ Electrolyte replacement (hypomagnesemia): Inject 1 g of this drug intramuscularly every 6 hours for 4 doses. Alternatively, 5 g of this drug may be added to 5 % dextrose injection or 0.9 % normal saline injection and administered intravenously over 3 hours. During treatment of the deficiency, monitor the patient's renal excretory function closely.
Child administration
○ Children: The safety of this drug has not been studied.

Ingredients

Manufacturer
Green Cross Wellbeing Co., Ltd.

Efficacy & effects

Electrolyte supplementation; suppression of convulsions and seizures (hypomagnesemia, eclampsia); prevention of uterine rigidity

  • Convulsions due to hypomagnesemia
  • seizures in eclampsia
  • uterine contractions
View approved original text

This medication is used to relieve convulsions caused by hypomagnesemia and prevent seizures in eclampsia. It also helps prevent uterine contractions and assists in maintaining electrolyte balance. It is primarily effective for treating symptoms associated with hypomagnesemia. It is used to improve a variety of symptoms.

How it is given

Adult administration

○ Convulsions due to hypomagnesemia: Inject 1 ∼ 2 g of magnesium sulfate intravenously (4.05 ∼ 8.1 mmol). ○ Eclamptic seizures: Inject 4 ∼ 5 g of this drug intravenously over 10 minutes (16.2 ∼ 20.25 mmol). ○ Prevention of uterine rigidity: Initially inject 4 g of this drug intravenously (16.2 mmol). A further 1 g may be administered. ○ Electrolyte replacement (hypomagnesemia): Inject 1 g of this drug intramuscularly every 6 hours for 4 doses. Alternatively, 5 g of this drug may be added to 5 % dextrose injection or 0.9 % normal saline injection and administered intravenously over 3 hours. During treatment of the deficiency, monitor the patient's renal excretory function closely.

Child administration

○ Children: The safety of this drug has not been studied.

Precautions

This medication should be handled carefully when cutting the glass ampoule, as glass shards may be introduced. Extra caution is advised for use in children and the elderly. It should not be administered to patients with impaired renal function, unconscious patients, patients with high serum magnesium levels, patients with cardiac conduction disorders, and myasthenia gravis patients. Use this medication with caution in children with intestinal parasitic diseases or patients with heart disease. Gastrointestinal symptoms such as vomiting or dry mouth may occur with this medication, and in rare cases, bradycardia or conduction disorders may develop. Rapid infusion may cause flushing of the skin or peripheral vasodilation and symptoms such as headache, heavy-headedness, tremors, and paresthesia may occur. In cases of overdose, magnesium toxicity may occur, presenting as sensations of warmth, thirst, hypotension, central nervous system depression, bradycardia, or respiratory paralysis, requiring immediate treatment. Calcium may be administered intravenously as an antidote. This medication may enhance central nervous system depressant effects when used with barbiturates, narcotics, sedatives, or general anesthetics. Caution should also be exercised as co-administration with iron supplements, certain antibiotics, or sodium fluoride may reduce drug absorption. It may be administered to pregnant women with eclampsia for the life of the mother and fetus; however, it may induce decreased fetal muscle tone, reflexes, and hypotension, so fetal heart rate should be monitored continuously. This medication should not be used within two hours after delivery due to the risk of neonatal respiratory depression. Its safety during breastfeeding is not established, so administration is not recommended unless specifically required. Elderly patients may have reduced bodily functions, therefore the administration rate should be slow, and dosages should be adjusted with caution. In overdose cases, serious side effects may occur depending on serum magnesium levels, so immediate discontinuation and antidote use should be taken if symptoms occur. Administer slowly via intravenous injection at a concentration of 10% or less; caution should be used as precipitates may form when mixed with other medications. Ensure thorough disinfection of the patient’s skin and injection apparatus prior to use, and use opened solutions immediately; do not reuse any remaining solution.

Side effects

  • vomiting
  • dry mouth
  • conduction disorders
  • bradycardia
  • flushing
  • peripheral vasodilation
  • headache
  • dizziness
  • tremors
  • tingling
Show 7 more
  • warmth sensation
  • thirst
  • hypotension
  • central nervous system depression
  • heart rate suppression
  • respiratory paralysis
  • warmth sensation at the injection site

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a sealed container that blocks light, such as an ampoule. It can also be stored in a sealed plastic container. It is important to maintain storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Brown ampoule containing a colorless and transparent liquid or injection in a colorless and transparent plastic container

Package unit

5 mL (ampoule) × 50 ampoules 20 mL (plastic ampoule) × 50 ampoules

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.